ArticleBreast cancer (Tokyo, Japan)2026
Risk of developing subsequent primary breast cancer among non-breast cancer survivors: a retrospective cohort study.
Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCancer survivors have an elevated risk of developing subsequent primary cancer, with breast cancer being one of the most common sites. Our study aimed to determine the incidence, patterns of, and risk factors for diagnosis of a subsequent primary breast cancer (SPBC) among survivors of adult non-breast cancers.
methodsAdult females diagnosed with a non-breast cancer in Alberta, Canada between 2000 and 2021 who survived ≥ 180 days were followed until SPBC diagnosis, death, or censoring on December 31, 2021. The incidence of SPBC was compared to the cancer-free general population using standardized incidence ratios (SIRs) and incidence rate differences (IRDs). Exploratory analyses of the association between sociodemographic/clinical factors and SPBC risk was conducted according to cancer type using Fine-Gray models adjusting for competing risk of death.
resultsThe study included 59,687 female cancer survivors, with 1113 incident SPBC cases. Overall, there was an increased risk of SPBC among survivors compared to the cancer-free general population (SIR = 1.15 [95% CI: 1.09-1.22], 10-year cumulative incidence = 2.0%). Significantly elevated SPBC risk was found among survivors of kidney, endometrial, and colorectal cancers, as well as obesity-related cancers combined. The increased risk of SPBC was primarily driven by early-stage and hormone receptor positive diagnoses. Depending on the primary cancer site, risk factors for SPBC included overweight/obese body mass index, diabetes, and cancer treatment.
conclusionsHistory of cancer should prompt discussion of breast cancer awareness, screening, and risk reduction. Future research is needed to inform personalized risk assessment for survivors of adult non-breast cancers.
Indexed as
Identifiers
42301386What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.